We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:11-20 of 10,193

FDA Expresses Priorities for Clinical Trial Efficiency, Artificial Intelligence
  • Knobbe Martens
  • USA
  • October 11 2018

The FDA has announced new goals to help modernize its procedures and respond to new Technologies. In a blog post by FDA Commissioner Scott Gottlieb


First CBD Drug Receives FDA Approval
  • Knobbe Martens
  • USA
  • October 11 2018

The FDA recently announced its approval of GW Pharmaceutical’s Epidiolex drug, described as the first ever plant-derived cannabinoid medicine in the


USDA Secretary Signals USDA Role Over Animal Cell Culture Technology Regulation Ahead of Joint USDA-FDA Meeting
  • Keller and Heckman LLP
  • USA
  • October 11 2018

As previously reported on this blog, the U.S. Department of Agriculture (USDA) and the Food and Drug Administration (FDA) announced that they will


California Passes First Cybersecurity Law Regulating IoT Devices
  • Squire Patton Boggs
  • USA
  • October 10 2018

California has become the first state in the US to adopt a cybersecurity law governing Internet of Things (IoT) devices. Senate Bill No. 327, signed


New draft guidance proposes a shift in how the FDA will evaluate certain device modifications
  • Hogan Lovells
  • USA
  • October 10 2018

On September 28, 2018, the U.S. Food and Drug Administration (FDA or the Agency) issued a draft guidance document, entitled "The Special 510(k)


Upon Further Review: The DEA Legalizes a Marijuana-Derived Drug
  • Shawe Rosenthal LLP
  • USA
  • October 10 2018

We’ve talked about this before. There is an ongoing tension between state laws decriminalizing or legalizing marijuana for medicinal purposes and


A Delaware First: Chancery Court Upholds Termination of Merger Based on MAE
  • Cozen O'Connor
  • USA
  • October 10 2018

On October 1, 2018, in Akorn, Inc. v. Fresenius Kabi AG, the Delaware Court of Chancery held for the first time that a buyer had validly terminated a


I Notified The Consumer, But Have I Done Enough?
  • Kane Russell Coleman Logan PC
  • USA
  • October 9 2018

Every year, millions of people in the United States develop foodborne illnesses. To help alleviate this issue, President Barack Obama signed the Food


Government Urges Reversal of Third Circuit Fosamax Decision
  • Reed Smith LLP
  • USA
  • October 9 2018

We would be hard pressed to think of a recent judicial decision we have blasted as hard or often as the Third Circuit’s Fosamax opinion. We deemed it


FDA Removes Clearance for 7 Synthetic Flavoring Substances
  • Keller and Heckman LLP
  • USA
  • October 9 2018

As we previously reported on this blog, a group of non-government organizations (NGOs) sued FDA in an effort to compel the Agency to act on a Food